menu

Joint Research Management Office

About us menu

JRMO performance

Clinical research overview

Financial headlines

  • Estimated Financial Turnover for JRMO managed clinical research (FY 2018-19):
    • Barts Health - £24m
    • Queen Mary School of Medicine and Dentistry - £71m
  • Of this figure, estimated Commercial clinical research Turnover (FY 2018-19):
    • Barts Health - £7m
    • Queen Mary School of Medicine and Dentistry - £13m

Research portfolio

  • Studies Sponsored (all types) between 1 September 2018 and 31 August 2019:
    • Barts Health – 32 (28 last year)
    • Queen Mary School of Medicine and Dentistry – 45 (37 last year)
  • Sponsored Studies actively recruiting at September 2019 - all the above
  • NIHR portfolio studies Sponsored, set up between 1 September 2018 and 31 August 2019:
    • Barts Health - 12 (9 last year)
    •  Queen Mary School of Medicine and Dentistry - 18 (15 last year)
  • Hosted NIHR portfolio studies set up between 1 September 2018 and 31 August 2019 (Barts Health only) - 310 (241 last year)
  • Hosted CTIMPs set up between 1 September and 31 August 2019 (Barts Health only) - 174 (134 last year)
  • Hosted Commercially Sponsored studies set up between 1 September 2018 and 31 August 2019 (Barts Health only) - 160 (120 last year)
  • Patients recruited to NIHR portfolio studies, 1 September 2018 to 31 August 2019 (Barts Health only) – 18,564 (17,199 last year)
  • European Union Clinical Trials Register (EU-CTR) of clinical trials registered within 1 year of completion, as at May 2019:
    • Barts Health as Sponsor– 88.2%
    • Queen Mary as Sponsor– 100%
    • Queen Mary/ Barts Health joint Sponsor– 100%

 JRMO activity

  • JRMO grant applications supported in Q1, 2019-2-:
    • Barts Health –  10, value £4.6m (Last quarter: 6, value £1m)
    • Queen Mary School of Medicine and Dentistry – 310, value £102.7m  (last quarter 250, value £100m)
  • JRMO contracts reviewed in Q1, 2019-20: 619 (last quarter 545)
  • JRMO invoices issued in Q1, 2019-20:
    • Barts Health –  TBC (last quarter 549, value £12m) 
    • Queen Mary School of Medicine and Dentistry – 533, value £9.2m (last quarter 709, value £14m) 

Historical Queen Mary statistical data

This data, previously located on the old JRMO intranet site, can be supplied on request by John Driscoll in the JRMO: j.p.driscoll@qmul.ac.uk  

Return to top